Hopefully won't be too long before he takes too much of one. (#+_+)
copper, reading your posts I can only imagine what an awkward tool you are in person. Holidays must be rough for someone who is probably liked by no one. Even the girl working at Chipotle who you've pining for months over thinks you are a creepy #$%$. Though you probably convinced yourself she's in love with you after mistakenly not being charged for guacamole one time.
It was written under the assumption that the market would understand the term "Draw Down Notice" If you knew, or searched it, it would make more sense. Knowing that the PR indicates that the price would be whatever the market price is WHEN Prana notifies them to sell shares.
Now Prana again has an ATM in place that they can use when/if cash is needed. Interesting to see MLV, George Zavoico's new place of employment, now has the shares rather than BNY Mellon.
Watch Maury Povich or swing by the department of health and human services. People with no brain seem to enjoy sex early and often.
man, I hope you have low commission rates. Honda is a great stock to buy at 30 and sell at 40 then keep the profit in free shares.
Also, the ASX 300 buys were done in a fixed deal, the sale could be done in a similar fashion. If not it will lower the price on the ASX but as we already know the U.S. market doesn't GAF where the ASX trades.
R/S would not keep them on the ASX 300, the market cap determines their spot. And pennies are the norm over there.
No placebos in the trial? All the placebos are in the extension trial... No, I know what you mean. The alternative to what I said is worse. Let's assume I'm wrong and the market is not skeptical. The trial is practically done so $1.65 has extension expectations baked in.
CHG, I agree. Prana could be managed much better. There is evidence of poor management littered all over the company history and we are lacking checks and balances needed to protect shareholders. This isn't something new, it has always been this way. Kempler provided the seed money for what is Prana and despite having no relative experience or knack for the role he has managed to stay CEO while residing as chairman over a friendly BOD that is uninvolved. This is a conflict of interest. Shoulson is an exception, and is basically carrying this company now.
Disadvantaged companies like Prana are strong candidates for patent extensions. Like everything else in life there are no guarantees. In the countries that matter Prana's protection will run out between 2023-2028. I believe most extensions add 4 years. They can't put AD on the back burner.